Intelligent Medical Imaging Scheduling

A next-generation medical imaging scheduling system that leverages artificial intelligence, machine learning, and digital twin technology to provide personalized treatment monitoring and optimize treatment outcomes.

The original patent addressed the need for determining a medical imaging schedule for a subject receiving treatment at a target site. However, the patent's limitations included reliance on initial imaging data, clinical information, and treatment information. The new inventive concept overcomes these limitations by incorporating real-time treatment response data, artificial intelligence, and machine learning algorithms to adapt the imaging schedule accordingly, enabling more accurate and personalized treatment monitoring.

The new inventive concept consists of a system and method for determining a medical imaging schedule that utilizes artificial intelligence to analyze real-time treatment response data and adapt the imaging schedule accordingly. The system includes a real-time data analytics module, a machine learning algorithm module, and an imaging protocol generator. The method involves utilizing machine learning algorithms to identify patterns in treatment response data and predict optimal imaging times, and generating a customized imaging schedule based on the predicted optimal imaging times. Additionally, the system can utilize a digital twin model of the subject's immune system to simulate treatment responses and predict optimal imaging times, enabling data-driven decision making.

The new inventive concept introduces the use of artificial intelligence, machine learning, and digital twin technology to adapt the medical imaging schedule in real-time, providing a paradigm shift in personalized treatment monitoring. The inventive step lies in the integration of these technologies to enable more accurate and effective treatment outcomes.

Alternative embodiments of the inventive concept could include the use of natural language processing to analyze clinical notes and identify relevant treatment response data, or the integration of other AI-powered tools to enhance the accuracy of the imaging schedule. Variations of the system could include the use of different machine learning algorithms or the incorporation of additional data sources, such as genomic data or wearable device data.

The new inventive concept has significant commercial potential in the medical imaging and healthcare industries, particularly in the areas of personalized medicine, precision oncology, and radiology. The system's ability to optimize treatment outcomes and reduce healthcare costs makes it an attractive solution for hospitals, clinics, and pharmaceutical companies.